Recombinant Human Antithrombin-III/AT3 protein (His tag)

A DNA sequence encoding the Human AT-Ⅲ protein (P01008) (1-464) was expressed with a C-His.

Introducing the Recombinant Human Antithrombin-III/AT3 Protein (HIS TAG), a cutting-edge biotechnological advancement in the field of protein therapeutics. This meticulously engineered product is designed to provide a highly purified and potent form of Antithrombin-III, a crucial protein involved in the regulation of blood clotting.

Crafted through state-of-the-art recombinant DNA technology, this protein is produced in a controlled laboratory environment, ensuring utmost purity and consistency. The inclusion of a HIS TAG enables facile purification and subsequent characterization, guaranteeing a product of exceptional quality.

The Recombinant Human Antithrombin-III/AT3 Protein (HIS TAG) exhibits remarkable bioactivity, effectively inhibiting the activity of thrombin, a key enzyme involved in the clotting cascade. By doing so, it plays a pivotal role in preventing the formation of blood clots, thereby reducing the risk of thromboembolic events.

This product is meticulously formulated to meet the stringent requirements of the pharmaceutical industry. It undergoes rigorous quality control measures, including extensive testing for purity, potency, and absence of contaminants. Each batch is meticulously characterized, ensuring consistent performance and reliability.

The Recombinant Human Antithrombin-III/AT3 Protein (HIS TAG) is supplied in a lyophilized form, preserving its stability and extending its shelf life. It is conveniently reconstituted with a suitable buffer, allowing for easy integration into various research and clinical applications.

This groundbreaking protein holds immense potential in the fields of hematology, thrombosis, and coagulation disorders. Its therapeutic applications extend to the treatment of hereditary antithrombin deficiency, disseminated intravascular coagulation, and prevention of thromboembolic events in high-risk patients.

In summary, the Recombinant Human Antithrombin-III/AT3 Protein (HIS TAG) represents a pinnacle of scientific innovation, offering a highly purified and potent form of Antithrombin-III. With its exceptional bioactivity, stringent quality control, and diverse therapeutic applications, this product stands as a testament to the advancements in protein therapeutics, promising improved patient outcomes and enhanced medical interventions.